N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.

MLA

Andersson, U., et al. “N-Butyldeoxygalactonojirimycin: A More Selective Inhibitor of Glycosphingolipid Biosynthesis than N-Butyldeoxynojirimycin, in Vitro and in Vivo.” Biochemical Pharmacology, vol. 59, no. 7, Apr. 2000, pp. 821–29. EBSCOhost, https://doi.org/10.1016/s0006-2952(99)00384-6.

APA

Andersson, U., Butters, T. D., Dwek, R. A., & Platt, F. M. (2000). N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo. Biochemical Pharmacology, 59(7), 821–829. https://doi.org/10.1016/s0006-2952(99)00384-6

Chicago

Andersson, U, T D Butters, R A Dwek, and F M Platt. 2000. “N-Butyldeoxygalactonojirimycin: A More Selective Inhibitor of Glycosphingolipid Biosynthesis than N-Butyldeoxynojirimycin, in Vitro and in Vivo.” Biochemical Pharmacology 59 (7): 821–29. doi:10.1016/s0006-2952(99)00384-6.